Frontiers in Immunology (Aug 2024)

High serum prevalence of autoreactive IgG antibodies against peripheral nerve structures in patients with neurological post-COVID-19 vaccination syndrome

  • Friederike A. Arlt,
  • Friederike A. Arlt,
  • Ameli Breuer,
  • Elli Trampenau,
  • Elli Trampenau,
  • Fabian Boesl,
  • Marieluise Kirchner,
  • Philipp Mertins,
  • Elisa Sánchez-Sendín,
  • Elisa Sánchez-Sendín,
  • Mahoor Nasouti,
  • Mahoor Nasouti,
  • Marie Mayrhofer,
  • Martin Blüthner,
  • Matthias Endres,
  • Matthias Endres,
  • Matthias Endres,
  • Matthias Endres,
  • Matthias Endres,
  • Harald Prüss,
  • Harald Prüss,
  • Christiana Franke

DOI
https://doi.org/10.3389/fimmu.2024.1404800
Journal volume & issue
Vol. 15

Abstract

Read online

BackgroundPatients suffering from neurological symptoms after COVID-19 vaccination (post-COVID-19 vaccination syndrome (PCVS)) have imposed an increasing challenge on medical practice, as diagnostic precision and therapeutic options are lacking. Underlying autoimmune dysfunctions, including autoantibodies, have been discussed in neurological disorders after SARS-CoV-2 infection and vaccination. Here, we describe the frequency and targets of autoantibodies against peripheral nervous system tissues in PCVS.MethodsSera from 50 PCVS patients with peripheral neurological symptoms after COVID-19 vaccination and 35 vaccinated healthy controls were used in this study. IgG autoreactivity was measured via indirect immunofluorescence assays on mouse sciatic nerve teased fibers. The frequencies of autoantibodies were compared between groups using Fisher’s exact test. Serum anti-ganglioside antibodies were measured in ganglioside blots. Autoantibody target identification was performed using immunoprecipitation coupled to mass spectrometry. Subsequent target confirmation was conducted via cell-based assays and ELISA.ResultsCompared with controls, PCVS patients had a significantly greater frequency of autoantibodies against peripheral nervous system structures (9/50(18%) vs 1/35(3%); p=0.04). Autoantibodies bound to paranodes (n=5), axons (n=4), Schmidt-Lanterman incisures (n=2) and Schwann cell nuclei (n=1). Conversely, antibodies against gangliosides were absent in PCVS patients. Target identification and subsequent confirmation revealed various subunits of neurofilaments as well as DFS-70 as autoantibody epitopes.ConclusionOur data suggest that autoantibodies against nervous system tissue could be relevant in PCVS patients. Autoantibodies against neurofilaments and cell nuclei with so far non-established links to this disease spectrum should be further elucidated to determine their biomarker potential.

Keywords